Factors affecting the release of nifedipine from a swellable elementary osmotic pump

Drug Delivery

Volumn 15, Issue 1, 2008, Pages 43-48

  Nokhodchi, Ali ^a   Momin, Mohammed N ^a   Shokri, Javad ^b   Shahsavari, Mahbobeh ^b   Rashidi, Parinaz Ahmad ^b  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Nifedipine; Orifice Size; Plasticizer; Swellable Elementary Osmotic Pump; Zero Order Release

Indexed keywords

CASTOR OIL; GELLING AGENT; NIFEDIPINE; OSMOTIC AGENT; PLASTICIZER; WETTING AGENT;

ARTICLE; DRUG ABSORPTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHOBICITY; MEMBRANE PERMEABILITY; OSMOTIC PUMP; PH MEASUREMENT; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; CASTOR OIL; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; GELS; HYDROGEN-ION CONCENTRATION; KINETICS; MEMBRANES, ARTIFICIAL; METHYLCELLULOSE; MODELS, CHEMICAL; NIFEDIPINE; OSMOSIS; PERMEABILITY; PLASTICIZERS; POTASSIUM CHLORIDE; SODIUM DODECYL SULFATE; SOLUBILITY; TABLETS; WATER; WETTING AGENTS;

EID: 38149101751     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540701829028     Document Type: Article

References (34)

1. Amende, M. T., Herbig, S. M., Korsmeyer, R. W., and Chidlaw, M. B. 2000. Osmotic drug delivery from asymmetric membrane filmcoated dosage forms, In Handbook of Pharmaceutical Controlled Release Technology, ed. Wise, D. L. 751-785. New York: Marcel Dekker.
2. Appel, L. E., Beyerinck, R. A., Chidlaw, M. B., Curatolo, W. J., Friesen, D. T., Smith, K. L., and Thombre, A. G. 2002. Hydrogel driven drug dosage form. U.S. Patent Application 20020015731.
3. Bode, H., Brendel, E., Ahr, G., Fuhr, U., Harder, S., and Staib, A. H. 1996. Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C-and 12Cnifedipine. Eur. J. Pharmacol. 50:195-201.
4. Cardinal, J. R. 2000. Controlled release osmotic drug delivery systems for oral applications. Drugs and the pharmaceutical sciences 102:411-444 (Transport Processes in Pharmaceutical Systems).
5. Cortese, R., and Theeuwes, F. 1982. Osmotic device with hydrogel driving member. U.S. Patent No. 4327725.
6. Curatolo, W. J., Waterman, K. C, Thombre, A. G., Fergione, M. B., Roy, M. C., Appel, L. E., Supplee, D., Friesen, D. T., Chidlaw, M. B., Beyerinck, R. A. 2001. Hydrogel-driven layered drug dosage form. US Patent Application, 20010044474.
7. Eckenhoff, B., Theeuwes, F., and Urquhart, J. 1981. Osmotically actuated dosage forms for rate-controlled drug delivery. Pharm. Technol. 5:35-44.
8. Fara, J.W. 1985. Osmotic delivery systems for research. Methods in enzymology. Drug Enzyme Targ. 112:470-484.
9. Grundy, J. S., and Foster, R. T. 1996. The nifidipine gasterointestinal therapeutic system evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clin. Pharmacokin. 30:28-51.
10. Hayase, N., Itagaki, Y. I, Ogawa, S., Akutsu, S., Inagaki, S., and Abibko, Y. 1994. Newly discovered photodegradation products of nifedipine in hospital prescriptions. J. Pharm. Sci. 83:532-538.
11. Herbig, S. M., Cardinal, J. R., Korsmeyer, R. W., and Smith, K. L. 1995. Asymmetric-membrane tablet coatings for osmotic drug delivery. J. Control. Rel. 35:127-136.
12. Higuchi, T., and Leeper, H. M. 1973a. Improved osmotic dispenser employing magnesium sulfate and magnesium chloride. U.S. Patent no. 3760804.
13. Higuchi, T., and Leeper, H.M. 1976. Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient. U.S. Patent no. 3995631.
14. Higuchi, T., and Leeper, H. M. 1973b. Osmotic disperser, U.S. Patent no. 3,732,865.
15. Higuchi, T. 1973c. Osmotic dispenser with collapsible supply container. U.S. Patent no. 3,760,805.
16. Langer, R. 1988. Drug delivery and targeting. Nature 392: 5-10.
17. Liu, L., Khang, G., Rhee, J. M., and Lee, H. B. 2000. Monolithic osmotic tablet system for nifedipine delivery. J. Control. Rel. 67: 309-322.
18. Lu, E. X., Jiang, Z. Q., Zhang, Q. Z., and Jiang, X. G. 2003. A water-insoluble drug monolithic osmotic tablet system utilizing gumarabic as an osmotic, suspending and expanding agent. J. Control. Rel. 92:375-382.
19. Rao, B. S., Kumar, N. R., Madhuri, K., Narayan, P. S., and Murthy, K. V. R. 2001. Osmotic drug delivery systems. East. Pharm. 44:21-28.
20. Rose, S., and Nelson, J. F. 1995. A continuous long-term injector. Aus. J. Exp. Biol. 33:415-420.
21. Santus, G., and Baker, R.W. 1995. Osmotic drug delivery: a review of the patent literature. J. Control. Rel. 35:1-21.
22. Shin, C. S., and Pae, A. N. 1988. Mechanistic studies on the photochemical degradation of nifedipine. Bull. Korean Chem. Soc. 9:271-274.
23. Swanson, D. R., Barclay, B. L, Wong, P. S., and Theeuwes, F. 1987. Nifedipine gastrointestinal therapeutic system. Am. J. Med. 83:3-9.
24. Theeuwes, F. 1975. Elementary osmotic pump. J. Pharm. Sci. 64:1987-1991.
25. Theeuwes, F. 1978. Osmotic system for delivering selected beneficial agents having varying degrees of solubility. U.S. Patent No. 4111201.
26. Thombre, A. G., Cardinal, J. R., DeNoto, A. R., Herbig, S. M., and Smith, K. L. 1999a. Asymmetric membrane capsules for osmotic drug delivery: I. Development of a manufacturing process. J. Control. Rel. 57:55-64.
27. Thombre, A. G., Cardinal, J. R., DeNoto, A. R., Herbig, S. M., and Smith, K. L. 1999b. Asymmetric membrane capsules for osmotic drug delivery: II. In vitro and in vivo drug release performance. J. Control. Rel. 57:65-73.
28. Thombre, A. G., DeNoto, A. R., and Gibbes, D. C. 1999c. Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients. J. Control Rel. 60:333-341.
29. Thombre, A. G., Zentner, G. M., and Himmelstein, K. J. 1989. Mechanism of water transport in controlled porosity osmotic devices. J. Membrane Sci. 40:279-310.
30. Verma, R. K., Krishna, D. M., and Garg, S. 2002. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Control. Rel. 79:7- 27.
31. Verma, R. K., Mishra, B., and Garg, S. 2000. Osmotically controlled oral drug delivery, Drug Dev. Ind. Pharm. 26:695-708.
32. Wong, P. S. L., Barclay, B. L., Deters, J. C., and Theeuwes, F. 1988. Osmotic device for administering certain drugs. U.S. Patent no. 4765989.
33. Zentner, G. M., McClelland, G. A., and Sutton, S. C. 1991. Controlled porosity solubility- and resin-modulated drug delivery systems for release of diltiazem hydrochloride. J. Control. Rel. 16:237-244.
34. Zentner, G. M., Rork, G. S., and Himmelstein, K. J. 1985. Osmotic flow through controlled porosity films: an approach to delivery ofwater soluble compounds. J. Control. Rel. 2:217-229.